Tirzepatide is expected to show similar or better results, but until SURPASS-CVOT is completed, semaglutide maintains an advantage in this domain
This was a chart review, in people with multiple comorbidities, against an active competitor not placebo of any kind
Learn more in: Wegovy Side Effects: What You Need to Know and Mounjaro Side Effects: What You Need to Know
Likewise, GLP-1(9-36)amide could reverse AD-related alterations in hippocampal synaptic plasticity and memory deficits, but did not alter levels of APP and A in APP/PS1 mice (218)
This approval means that the medication has regulatory authorization for use in the EU
These risks include effects on organ development, fetal weight, and even a higher likelihood of pregnancy loss in some cases